CN104524399A - Traditional Chinese medicine composition treating bronchial asthma - Google Patents
Traditional Chinese medicine composition treating bronchial asthma Download PDFInfo
- Publication number
- CN104524399A CN104524399A CN201410690618.5A CN201410690618A CN104524399A CN 104524399 A CN104524399 A CN 104524399A CN 201410690618 A CN201410690618 A CN 201410690618A CN 104524399 A CN104524399 A CN 104524399A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- traditional chinese
- medicine composition
- parts
- bronchial asthma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition treating bronchial asthma. traditional Chinese medicine considers that bronchial asthma belongs to traditional chinese medicine asthma category. Qi movement stagnation and qi counterflow are pathogenesis key causing asthma attack, and the induced factors comprise exogenous disease caused by six climatic exopathogens, internal injury caused by excess of seven emotions, intemperance of taking food, and overstrain and over indulgency. The traditional Chinese medicine composition employs traditional Chinese medicines all-grass of khas aletris, juglans cathaycnsis kernel, stizolobium cochinchinense, rex woodbetony, flos pruni mume, villous amomum flower and peduncle, orthosiphon wulfenioides, herb of denseflower bulbophyllum, and rhizome of longspurred fairybells which have the efficacy of tonifying kidney and consolidating body resistance, soothing the liver and fortifying spleen, clearing lung heat and tonifying qi, regulating qi and resolving phlegm, and a decoction is prepared by adding water into the above medicinal materials for decoction. Through clinic tests, the traditional Chinese medicine composition has the total effective rate of 92.9% which is obviously better than that of a contrast group, and is substantial in curative effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, particularly relate to a kind of Chinese medicine composition for the treatment of bronchial asthma.
Background technology
Bronchial asthma is called for short asthma, is common ictal, pulmonary hypersensitivity disease.Outbreak generally has seasonality.Modern medicine study is thought, bronchial asthma is a kind of chronic airway inflammation, its pathogeny and the airway obstruction caused by chronic allergy inflammation and airway reactivity increase closely related, treatment center of gravity has been that main moving to is suppressed allergy, improved airway allergy inflammation from releasing bronchospasm, their existence makes the treatment of asthma become more difficult, and this sick sickness rate has ascendant trend year by year, seriously endanger the physical and mental health of people.The many employings of western medical treatment oral ammonia bitter edible plant alkali sheet is treated, and long-term taking can produce the side effect such as Nausea and vomiting, emotional, insomnia, even there will be the symptom such as tachycardia, arrhythmia.Applicant is through clinical practice for many years, and application treatment by Chinese herbs bronchial asthma, achieves good effect.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine composition for the treatment of bronchial asthma.The pathological characters of bronchial asthma can be summarized with " evil, empty, silt " three words, lung, spleen, suffer from a deficiency of the kidney that to decline be this, tired, turbid, congestion is mark, the stagnation of QI, QI rising in reverse order are that the pathogenesis of asthma attack is crucial, and the traditional Chinese medical science thinks that its risk factor is that six climate exopathogens diseases caused by exogenous pathogenic factor, internal injury caused by excess of seven emotions, intemperance of taking food, labor are for excessively.Bronchial asthma belongs to Chinese medicine " asthma " category.Controlling should reinforcing kidney and strengthening resistance, soothing liver and strengthening spleen, lung heat clearing QI invigorating, activating QI to eliminate phlegm.
The object of the invention is to be achieved through the following technical solutions, the Chinese medicine composition of this treatment bronchial asthma is made up of the Chinese medicine of following weight portion: Herba Aletridis Khasianae 20-30 part, Semen juglandis cathayensis 15-25 part, Semen Stizolobii Cochinchinensis 6-9 part, Pedicularis rex C. B. Clarke ex Maxim. 20-30 part, Flos Pruni mume 3-4 part, Flos Amomi villosi 1.5-3 part, Radix Roscoeae Intermediae 10-15 part, Herba Bulbophylli Odoratissim 15-25 part, Rhizoma Dispori Calcarati 10-15 part.
Preferably, Herba Aletridis Khasianae 25 parts, Semen juglandis cathayensis 20 parts, Semen Stizolobii Cochinchinensis 7.5 parts, Pedicularis rex C. B. Clarke ex Maxim. 25 parts, Flos Pruni mume 3.5 parts, Flos Amomi villosi 2.5 parts, Radix Roscoeae Intermediae 13 parts, Herba Bulbophylli Odoratissim 20 parts, Rhizoma Dispori Calcarati 13 parts.
Above-mentioned Chinese medicine decocting is made decoction by preparation method.
Fang Zhong: Herba Aletridis Khasianae, Semen juglandis cathayensis fill blood, moistening the lung and resolving the phlegm; Semen Stizolobii Cochinchinensis is calmed the nerves Dingchuan, invigorating the spleen and replenishing QI, the kidney invigorating pain relieving; Pedicularis rex C. B. Clarke ex Maxim. benefiting vital QI and blood, invigorating spleen to remove dampness; Flos Pruni mume is soothing the liver to reduce phlegm; Flos Amomi villosi is regulated the flow of vital energy and is eliminated the phlegm; Radix Roscoeae Intermediae lung-clearing asthma-relieving; Herba Bulbophylli Odoratissim moistening the lung and resolving phlegm: promoting the circulation of QI to relieve pain; Rhizoma Dispori Calcarati promoting the production of body fluid and benefiting QI, nourishing YIN and moistening the lung.
Clinical data
1, the routine patient of physical data 84 all meets bronchial asthma diagnostic criteria, is divided into treatment group and each 42 examples of matched group at random.Treatment group: man 22 example, female 20 example, 18 ~ 50 years old age, average 40.5 years old, the course of disease 1.0 ~ 20 years.Matched group: man 24 example, female 18 example, the age is 20 ~ 55 years old, average 41.3 years old, the course of disease 1.5 years ~ 22 years.Two groups in sex, age, the course of disease, the state of an illness etc. without significant difference (P > 0.05), there is comparability.
2, diagnostic criteria (1) recurrent exerbation is panted, out of breath, uncomfortable in chest or cough, how with to contact allergen, cold air, physics, chemical irritation and viral upper respiratory tract infection, motion etc. relevant.(2) during outbreak at two lung audible and be dispersed in or diffusivity, the wheezing sound based on expiratory phase, expiratory phase prolongation.(3) above-mentioned symptom and sign can be alleviated or spontaneous remission through treatment.(4) panting except caused by other diseases, out of breath, uncomfortable in chest and cough.
3, Therapeutic Method treatment group takes Chinese medicine composition of the present invention, take Herba Aletridis Khasianae 25g, Semen juglandis cathayensis 20g, Semen Stizolobii Cochinchinensis 7.5g, Pedicularis rex C. B. Clarke ex Maxim. 25g, Flos Pruni mume 3.5g, Flos Amomi villosi 2.5g, Radix Roscoeae Intermediae 13g, Herba Bulbophylli Odoratissim 20g, Rhizoma Dispori Calcarati 13g, decocting becomes decoction, potion, divided and sooner or later took for 2 times every day.Matched group gives oral aminophylline tablets, a 0.1g, 3 times on the one.15 days each courses for the treatment of, two groups of courses for the treatment of are 3 courses for the treatment of.
4, criterion of therapeutical effect is cured: cough, cough up phlegm, pant, uncomfortable in chest, pulmonary rale all disappears, pulmonary function, eosinophilic granulocyte, IgG, 1gE are all normal, in two years without recurring; Effective: clinical symptoms, sign disappear substantially.Lab testing reaches or substantially close to normal; Effective: clinical symptoms is improved, and lab testing takes a turn for the better to some extent, and recurrent number is than former minimizing; Invalid: symptom and sign is without improvement, and lab testing is without change or increase the weight of.
5, therapeutic outcome two groups treats comparitive study after three courses for the treatment of, and treatment group 42 example, wherein cures 25 examples (59.5%), effective 9 examples (21.4%), effective 5 examples (11.9%), invalid 3 examples (7.1%), total effective rate 92.9%; Matched group 42 example, wherein cures 8 examples (19.0%), effective 9 examples (21.4%), effective 13 examples (30.9%), invalid 12 examples (28.6%), total effective rate 71.4%.Two groups are compared, and treatment group cure rate, total effective rate are obviously better than matched group, have comparability (P < 0.05).
Detailed description of the invention
Embodiment one: take Herba Aletridis Khasianae 25g, Semen juglandis cathayensis 20g, Semen Stizolobii Cochinchinensis 7.5g, Pedicularis rex C. B. Clarke ex Maxim. 25g, Flos Pruni mume 3.5g, Flos Amomi villosi 2.5g, Radix Roscoeae Intermediae 13g, Herba Bulbophylli Odoratissim 20g, Rhizoma Dispori Calcarati 13g, becomes decoction by above-mentioned Chinese medicine decocting.
Embodiment two: take Herba Aletridis Khasianae 30g, Semen juglandis cathayensis 25g, Semen Stizolobii Cochinchinensis 9g, Pedicularis rex C. B. Clarke ex Maxim. 20g, Flos Pruni mume 4g, Flos Amomi villosi 3g, Radix Roscoeae Intermediae 15g, Herba Bulbophylli Odoratissim 25g, Rhizoma Dispori Calcarati 15g, becomes decoction by above-mentioned Chinese medicine decocting.
Embodiment three: take Herba Aletridis Khasianae 20g, Semen juglandis cathayensis 15g, Semen Stizolobii Cochinchinensis 6g, Pedicularis rex C. B. Clarke ex Maxim. 30g, Flos Pruni mume 3g, Flos Amomi villosi 1.5g, Radix Roscoeae Intermediae 10g, Herba Bulbophylli Odoratissim 15g, Rhizoma Dispori Calcarati 10g, becomes decoction by above-mentioned Chinese medicine decocting.
Claims (2)
1. treat a Chinese medicine composition for bronchial asthma, it is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Aletridis Khasianae 20-30 part, Semen juglandis cathayensis 15-25 part, Semen Stizolobii Cochinchinensis 6-9 part, Pedicularis rex C. B. Clarke ex Maxim. 20-30 part, Flos Pruni mume 3-4 part, Flos Amomi villosi 1.5-3 part, Radix Roscoeae Intermediae 10-15 part, Herba Bulbophylli Odoratissim 15-25 part, Rhizoma Dispori Calcarati 10-15 part.
2. a kind of Chinese medicine composition for the treatment of bronchial asthma according to claim 1, is characterized in that this Chinese medicine composition is made up of the Chinese medicine of following weight portion: Herba Aletridis Khasianae 25 parts, Semen juglandis cathayensis 20 parts, Semen Stizolobii Cochinchinensis 7.5 parts, Pedicularis rex C. B. Clarke ex Maxim. 25 parts, Flos Pruni mume 3.5 parts, Flos Amomi villosi 2.5 parts, Radix Roscoeae Intermediae 13 parts, Herba Bulbophylli Odoratissim 20 parts, Rhizoma Dispori Calcarati 13 parts.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410690618.5A CN104524399A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition treating bronchial asthma |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410690618.5A CN104524399A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition treating bronchial asthma |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104524399A true CN104524399A (en) | 2015-04-22 |
Family
ID=52840155
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410690618.5A Pending CN104524399A (en) | 2014-11-17 | 2014-11-17 | Traditional Chinese medicine composition treating bronchial asthma |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104524399A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106729253A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of tibet roscoea root lung-clearing asthma-relieving electuary and preparation method thereof |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050084725A (en) * | 2004-02-24 | 2005-08-29 | 학교법인 영남학원 | Composition comprising an extract of anthriscus sylvesstris for prevention and treatment of inflammatory or allergy diseases |
CN102908565A (en) * | 2012-10-24 | 2013-02-06 | 尹甲仑 | Chinese herbal medicine decoction for curing bronchial asthma and preparation method of Chinese herbal medicine decoction |
-
2014
- 2014-11-17 CN CN201410690618.5A patent/CN104524399A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050084725A (en) * | 2004-02-24 | 2005-08-29 | 학교법인 영남학원 | Composition comprising an extract of anthriscus sylvesstris for prevention and treatment of inflammatory or allergy diseases |
CN102908565A (en) * | 2012-10-24 | 2013-02-06 | 尹甲仑 | Chinese herbal medicine decoction for curing bronchial asthma and preparation method of Chinese herbal medicine decoction |
Non-Patent Citations (1)
Title |
---|
王勇: "《辨质辨病辨证临床应用手册—中西医结合快速诊疗六十病》", 30 September 2014 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106729253A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of tibet roscoea root lung-clearing asthma-relieving electuary and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101391077B (en) | Preparation method of traditional Chinese medicine for treating chronic pelvic inflammatory disease | |
CN103768541A (en) | Medicine for treating chronic bronchitis | |
CN107596328A (en) | A kind of medicine for treating allergic rhinitis | |
CN102274385B (en) | Medicament for treating nasosinusitis and preparation method thereof | |
CN103948675A (en) | Traditional Chinese medicine for treating chronic rhinitis | |
CN101422558B (en) | Traditional Chinese medicine for treating globus hystericus | |
CN104069358A (en) | Chinese herba preparation for treating bronchial asthma | |
CN103816422B (en) | A kind of Chinese medicine composition for the treatment of measles and preparation method thereof | |
CN103142733B (en) | Chinese medicine composition for treating upper respiratory infection | |
CN104306793A (en) | Chinese herba preparation for treating lobar pneumonia | |
CN104623555A (en) | Traditional Chinese medicine preparation for treating acute asthmatic bronchitis and preparation method thereof | |
CN103638488A (en) | Traditional Chinese medicine composition for treating pleurisy | |
CN104524399A (en) | Traditional Chinese medicine composition treating bronchial asthma | |
CN103463604A (en) | Drug for treating cough and asthma | |
CN103877383A (en) | Traditional Chinese medicine preparation for treating bronchial asthma with syndrome of intermin-gled phlegm and qi | |
CN106138279A (en) | Pharmaceutical composition for the treatment of rhinitis and preparation method thereof | |
CN104367975A (en) | Flos farfarae paste for relieving cough and eliminating phlegm | |
CN103142872B (en) | Chinese medicine composition for treating wind-heat common cold | |
CN103830481A (en) | Medicine for treating recurrent respiratory tract infection of children | |
CN104173716A (en) | Traditional Chinese medicine decoction treating acute and chronic pharyngitis | |
CN105770455A (en) | Traditional Chinese medicinal preparation for treating bronchial asthma | |
CN105816847A (en) | Traditional Chinese medicine composition for treating rhinitis | |
CN106074784A (en) | The Chinese medicine for the treatment of coronary heart disease and myocardial ischemia | |
CN101095927A (en) | Medicine for treating rheumatism or postpartum rheumatism | |
CN104940622A (en) | Traditional Chinese medicine external lotion for treating infantile bronchitis and nursing method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150422 |
|
RJ01 | Rejection of invention patent application after publication |